|
Advancing the Understanding and Consideration of Behavioral Models of Adherence |
Monday, May 27, 2024 |
12:00 PM–12:50 PM |
Convention Center, 100 Level, 103 C |
Area: DDA/CBM; Domain: Service Delivery |
CE Instructor: Craig Strohmeier, Psy.D. |
Chair: Craig Strohmeier (Kennedy Krieger Institute and Johns Hopkins University School of Medicine) |
ADAM M. BRIGGS (Eastern Michigan University) |
KATIE BROWN (Utah State University) |
TIMOTHY R. MOORE (University of Minnesota Medical School) |
Abstract: Allen and Warzak (2000) articulated the importance of analyzing contingencies that control parental adherence to produce durable behavioral treatment plans implemented by caregivers over time. Further, they highlighted that operationalizing and measuring adherence poses distinct challenges for the clinician and applied researcher since, by definition, adherence involves independent implementation of a treatment plan in the absence of direct oversight by the clinician. Over 20 years later, adherence is still reported infrequently in the behavior analytic literature despite growing evidence of the gap between observed integrity and adherence in natural environments. This panel discussion will raise awareness of the problem of nonadherence in our field, and the continued need for establishing an empirically based process to increase and sustain adherence. Primary aims of the panel include a discussion between panel members and the audience around a) the importance of adherence, and the distinction between treatment adherence and treatment integrity; b) caregiver barriers and considerations for developing interventions in a manner that will occasion adherence; and c) leveraging behavioral models of adherence to create treatment plans contextualized in the preferences, values, and capacities that will sustain ongoing treatment implementation. |
Instruction Level: Advanced |
Target Audience: Experience in the development, and supervising the development, of function-based behavioral treatment plans, conducting treatment evaluations with caregiver involvement, and modifying treatments to create feasible terminal treatments. Additionally, audience members should have experience in caregiver consultation after behavioral treatment plans are transferred from clinical environments to naturalistic settings. |
Learning Objectives: At the conclusion of the panel discussion, participants will be able to: (1) describe the differences between treatment integrity and treatment adherence; (2) list potential caregiver barriers to implementing treatment plans in home and community settings, and ways to consider these barriers at the outset of treatment planning; and (3) provide examples of how to use evidence-based practices to establish and maintain caregiver adherence with treatment plans. |
Keyword(s): Adherence, Caregiver Training, Functional Assessment, Treatment Integrity |
|
|